Systemic treatments in favorable and very favorable risk metastatic renal cell carcinoma (mRCC): Real world evidence from the International mRCC Database Consortium (IMDC)

被引：0
|
作者：
Zarba, Martin
Ferrier, Evan
Wells, Connor
El Zarif, Talal
Basappa, Naveen S.
Ebrahimi, Hedyeh
Mckay, Rana R.
Wood, Lori
Beuselinck, Benoit
Suarez, Cristina
Takemura, Kosuke
Lalani, Aly-Khan A.
Li, Haoran
Spain, Lavinia Anne
Templeton, Arnoud J.
Powles, Thomas
Bjarnason, Georg A.
de Velasco, Guillermo
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Calgary, AB, Canada
[3] Barts Canc Inst, London, England
[4] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA
[5] Univ Alberta, Cross Canc Inst, Dept Med Oncol, Edmonton, AB, Canada
[6] City Hope Comprehens Canc Ctr, Duarte, CA USA
[7] Univ Calif San Diego, La Jolla, CA USA
[8] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
[9] UZ Leuven, Leuven, Belgium
[10] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Med Oncol, Barcelona, Spain
[11] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[12] McMaster Univ, Hamilton, ON, Canada
[13] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA
[14] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[15] St Clara Hosp, Basel, Switzerland
[16] Queen Mary Univ London, Barts Canc Inst, London, England
[17] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[18] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
[19] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The very favorable metastatic renal cell carcinoma (mRCC) risk group: Data from the International Metastatic RCC Database Consortium (IMDC).
    Schmidt, Andrew Lachlan
    Xie Wanling
    Gan, Chun Loo
    Wells, Connor
    Dudani, Shaan
    Donskov, Frede
    Porta, Camillo
    Suarez, Cristina
    Szabados, Bernadett
    Wood, Lori
    Ruiz Morales, Jose Manuel
    Tran, Ben
    Bjarnason, Georg A.
    Yuasa, Takeshi
    Beuselinck, Benoit
    Hansen, Aaron Richard
    Agarwal, Neeraj
    Bakouny, Ziad
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [2] Third line therapy in metastatic renal cell carcinoma (mRCC): results from the international mRCC database consortium (IMDC)
    Stukalina, Igor
    Wellsa, J. Connor
    Donskovb, Frede
    Rinic, Brian I.
    Leed, Jae-Lyun
    Bjarnasone, Georg A.
    Beuselinckf, Benoit
    Smoragiewicz, Martin
    Alvah, Ajjai Shivaram
    Srinivasi, Sandy
    Woodi, Lori
    Saleemk, Sadia
    Pal, Sumanta Kumar
    Yuasam, Takeshi
    Broomn, Reuben James
    Kanesvaran, Ravindran
    Bamiasp, Aristotelis
    Knoxq, Jennifer J.
    Henga, Daniel Y. C.
    Choueirir, Toni K.
    BJU INTERNATIONAL, 2015, 116 : 21 - 21
  • [3] Sites of metastasis and survival in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Dudani, Shaan
    de Velasco, Guillermo
    Wells, Connor
    Gan, Chun Loo
    Donskov, Frede
    Porta, Camillo
    Fraccon, Anna
    Pasini, Felice
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Pal, Sumanta K.
    Hotte, Sebastien J.
    Lalani, Aly-Khan A.
    Yuasa, Takeshi
    Kanesvaran, Ravindran
    Reaume, M. Neil
    Canil, Christina M.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [4] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Sites of metastasis and survival in metastatic renal-cell carcinoma (mRCC): Resuits from the international mRCC Database Consortium (IMDC)
    Dudani, Shaan
    de Velasco, Guillermo
    Wells, J. Connor
    Gan, Chun Loo
    Donskov, Frede
    Porta, Camillo
    Fraccon, Anna
    Pasini, Felice
    Hansen, Aaron
    Bjarnason, Georg
    Beuselinck, Benoit
    Pal, Sumanta K.
    Hotte, Sebastien
    Lalani, Aly-Khan A.
    Yuasa, Takeshi
    Kanesvaran, Ravindran
    Reaume, M. Neil
    Canil, Christina
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 4 - 4
  • [6] Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Stukalin, Igor
    Wells, J. Connor
    Fraccon, Anna
    Pasini, Felice
    Porta, Camillo
    Lalani, Aly-Khan A.
    Srinivas, Sandy
    Bowman, I. Alex
    Brugarolas, James
    Lee, Jae-Lyun
    Donskov, Frede
    Beuselinck, Benoit
    Bamias, Aristotelis
    Rini, Brian, I
    Sim, Hao-Wen
    Agarwal, Neeraj
    Rha, Sun-Young
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    KIDNEY CANCER, 2018, 2 (01) : 31 - 36
  • [7] Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Stukalin, Igor
    Wells, Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Porta, Camillo
    Moreira, Raphael Brandao
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [8] Low versus low-intermediate risk metastatic renal cell carcinoma (mRCC): Contemporary data from the International mRCC Database Consortium (IMDC).
    Chehade, Razane El Hajj
    Xie, Wanling
    Semaan, Karl
    Eid, Marc
    Machaalani, Marc
    Nawfal, Rashad
    Saad, Eddy
    Saliby, Renee Maria
    Steiner, Clara
    Yekeduz, Emre
    Wells, Connor
    Maj, David
    Zarba, Martin
    Pal, Sumanta Kumar
    Suarez, Cristina
    Takemura, Kosuke
    Basappa, Naveen S.
    Baca, Sylvan C.
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [9] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] Real world outcomes of first line (1L) nivolumab and ipilimumab (NIVO IPI) in metastatic renal cell carcinoma (mRCC): An update from the International mRCC Database Consortium (IMDC).
    Ferrier, Evan
    Lemelin, Audreylie
    Powles, Thomas
    Pal, Sumanta Kumar
    Ebrahimi, Hedyeh
    Agarwal, Neeraj
    Beuselinck, Benoit
    Bjarnason, Georg A.
    Wood, Lori
    Canil, Christina M.
    Saliby, Renee Maria
    de Velasco, Guillermo
    Mckay, Rana R.
    Tran, Ben
    Suarez, Cristina
    Templeton, Arnoud J.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 395 - 395
12345